pxl.store / Shutterstock.com (The Royal Courts of Justice, where the English High Court is based.)

1 June 2015

English court grants Warner’s appeal in Lyrica second medical use case

The English Court of Appeal has said pharmaceutical company Warner-Lambert has a viable argument that Actavis indirectly infringed a second medical use patent covering Warner’s drug Lyrica (pregabalin).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Moderna VP and regulatory expert moves to private practice

2 February 2026 The third European life sciences hire in recent months brings in-house regulatory expertise from Moderna in Munich.

Careers

Winston & Strawn and Taylor Wessing UK seal ‘powerhouse’ merger

30 January 2026 Transatlantic ‘powerhouse’ Winston Taylor is set to launch in May 2026, with a particular focus on technology, life sciences and transatlantic services.

Careers

Pearce IP grows practice with senior patent hire

29 January 2026 Melbourne-based firm adds senior attorney with over 25 years of experience in therapeutics, diagnostics and biologics as demand for specialist patent services rises.

More features

Moderna VP and regulatory expert moves to private practice

Winston & Strawn and Taylor Wessing UK seal ‘powerhouse’ merger

Pearce IP grows practice with senior patent hire

Sanofi suffers setback in insulin monopoly dispute

Firm adds seven-lawyer team in second major merger

Eli Lilly’s Mounjaro tops list of cyber squatter targets

The quantum advantage: IP considerations for the next generation of life sciences innovation

Fed Circ overturns PTAB decision in $83.4m DNA case

English court grants Warner’s appeal in Lyrica second medical use case

More on this story

Editor's picks

Editor's picks

More features